156 related articles for article (PubMed ID: 14526401)
21. Does lymphocyte cross-matching predict acute rejection and graft survival in liver transplantation?
Joo DJ; Ju MK; Huh KH; Kim MS; Choi GH; Choi JS; Jeon KO; Kim SI
Transplant Proc; 2012 Mar; 44(2):418-20. PubMed ID: 22410032
[TBL] [Abstract][Full Text] [Related]
22. Living donor liver transplantation in high-risk vs. low-risk patients: optimization using statistical models.
Durand F; Belghiti J; Troisi R; Boillot O; Gadano A; Francoz C; de Hemptinne B; Mallet A; Valla D; Golmard JL
Liver Transpl; 2006 Feb; 12(2):231-9. PubMed ID: 16447208
[TBL] [Abstract][Full Text] [Related]
23. Fatal graft-versus-host disease after living donor liver transplantation: differential impact of donor-dominant one-way HLA matching.
Kamei H; Oike F; Fujimoto Y; Yamamoto H; Tanaka K; Kiuchi T
Liver Transpl; 2006 Jan; 12(1):140-5. PubMed ID: 16382466
[TBL] [Abstract][Full Text] [Related]
24. Effect of HLA matching and T- and B-cell crossmatch on acute rejection and graft survival following liver transplantation.
Chen M; Wade J; Levy GA; Greig PD
Transplant Proc; 1994 Oct; 26(5):2695-6. PubMed ID: 7940844
[No Abstract] [Full Text] [Related]
25. Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study.
Opelz G; Döhler B; Süsal C
Hum Immunol; 2009 Aug; 70(8):627-30. PubMed ID: 19375469
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
[TBL] [Abstract][Full Text] [Related]
27. Implications of a positive crossmatch in liver transplantation: a 20-year review.
Ruiz R; Tomiyama K; Campsen J; Goldstein RM; Levy MF; McKenna GJ; Onaca N; Susskind B; Tillery GW; Klintmalm GB
Liver Transpl; 2012 Apr; 18(4):455-60. PubMed ID: 22139972
[TBL] [Abstract][Full Text] [Related]
28. The role of apheresis therapy for ABO incompatible living donor liver transplantation: the Kyoto University experience.
Kozaki K; Egawa H; Ueda M; Oike F; Yoshizawa A; Fukatsu A; Takada Y
Ther Apher Dial; 2006 Oct; 10(5):441-8. PubMed ID: 17096700
[TBL] [Abstract][Full Text] [Related]
29. Relevance of HLA compatibility in living donor liver transplantation: the double-edged sword associated with the patient outcome.
Uchiyama H; Kayashima H; Matono R; Shirabe K; Yoshizumi T; Ikegami T; Soejima Y; Matsuura T; Taguchi T; Maehara Y
Clin Transplant; 2012; 26(5):E522-9. PubMed ID: 23061761
[TBL] [Abstract][Full Text] [Related]
30. Longterm outcomes for whole and segmental liver grafts in adult and pediatric liver transplant recipients: a 10-year comparative analysis of 2,988 cases.
Hong JC; Yersiz H; Farmer DG; Duffy JP; Ghobrial RM; Nonthasoot B; Collins TE; Hiatt JR; Busuttil RW
J Am Coll Surg; 2009 May; 208(5):682-9; discusion 689-91. PubMed ID: 19476815
[TBL] [Abstract][Full Text] [Related]
31. Characterization of liver enzymes on living related liver transplantation patients with acute rejection.
Chiu KW; Chen YS; de Villa VH; Wang CC; Eng HL; Wang SH; Liu PP; Jawan B; Huang TL; Cheng YF; Chen CL
Hepatogastroenterology; 2005; 52(66):1825-7. PubMed ID: 16334785
[TBL] [Abstract][Full Text] [Related]
32. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
[TBL] [Abstract][Full Text] [Related]
33. Influence of panel-reactive antibody on survival and rejection after lung transplantation.
Gammie JS; Pham SM; Colson YL; Kawai A; Keenan RJ; Weyant RJ; Griffith BP
J Heart Lung Transplant; 1997 Apr; 16(4):408-15. PubMed ID: 9154951
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.
Schmeding M; Neumann UP; Puhl G; Bahra M; Neuhaus R; Neuhaus P
Liver Transpl; 2007 May; 13(5):687-92. PubMed ID: 17457911
[TBL] [Abstract][Full Text] [Related]
35. Analysis of CD8+CD28- T-suppressor cells in living donor liver transplant recipients.
Lin YX; Wang LL; Yan LN; Cai P; Li B; Wen TF; Zeng Y
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):241-6. PubMed ID: 19502162
[TBL] [Abstract][Full Text] [Related]
36. Model for End Stage Liver Disease score does not predict graft survival after living donor liver transplantation.
Dulundu E; Sugawara Y; Kishi Y; Akamatsu N; Kaneko J; Makuuchi M
Hepatogastroenterology; 2006; 53(71):781-2. PubMed ID: 17086888
[TBL] [Abstract][Full Text] [Related]
37. Survival after pediatric liver transplantation: why does living donation offer an advantage?
Austin MT; Feurer ID; Chari RS; Gorden DL; Wright JK; Pinson CW
Arch Surg; 2005 May; 140(5):465-70; discussion 470-1. PubMed ID: 15897442
[TBL] [Abstract][Full Text] [Related]
38. Human leukocyte antigen-C in short- and long-term liver graft acceptance.
Moya-Quiles MR; Muro M; Torío A; Sánchez-Bueno F; Miras M; Marín L; García-Alonso AM; Parrilla P; Dausset J; Alvarez-López MR
Liver Transpl; 2003 Mar; 9(3):218-27. PubMed ID: 12619017
[TBL] [Abstract][Full Text] [Related]
39. Small-for-size graft in adult living-donor liver transplantation.
Lee HH; Joh JW; Lee KW; Kim SJ; Lee DS; Park JH; Choi SH; Heo JS; Hyon WS; Kwak MS; Lee SK
Transplant Proc; 2004 Oct; 36(8):2274-6. PubMed ID: 15561216
[TBL] [Abstract][Full Text] [Related]
40. Refractory acute rejection in a living related liver transplantation.
Noritomi T; Sugawara Y; Kaneko J; Matsui Y; Makuuchi M
Hepatogastroenterology; 2003; 50(54):2192-3. PubMed ID: 14696495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
